Effects of Female Hormone Drugs During Pregnancy
Author Information
Author(s): Hemminki E, Gissler M, Toukomaa H
Primary Institution: National Research and Development Centre for Welfare and Health, Health Services Research Unit
Hypothesis
Is the use of female sex hormone drugs during pregnancy a risk factor for malformations and cancer in mothers and their children?
Conclusion
The study found that hormone drug exposure during pregnancy is linked to higher rates of malformations in children but not to increased cancer risk in mothers.
Supporting Evidence
- The study included 2052 hormone-drug exposed mothers and 2038 control mothers.
- Higher rates of genital malformations were observed in male infants exposed to hormone drugs.
- No significant differences in cancer rates were found between the exposed and control groups.
Takeaway
Taking certain hormone drugs while pregnant might make babies more likely to have problems, but it doesn't seem to cause cancer in moms later.
Methodology
A retrospective cohort study comparing hormone-drug exposed mothers and control mothers, with cancer cases identified through national registers.
Limitations
The study had low power to detect cancer cases among offspring, and potential confounding factors may have influenced the results.
Participant Demographics
Mothers from maternity centres in Helsinki, with a control group of non-exposed mothers.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website